Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of European Eltech recommended that dividends be paid for 2023

5/28/24 EELT

Authorities begin deoffshorization of Akron

5/28/24 AKRN

Vladimir Evtushenkov and Yury Maximov may set up a JV in cybersecurity

5/28/24 AFKS

Board of Directors of Bashneft recommended that dividends be paid for 2023

5/27/24 BANE

PhosAgro reports for 3 months of 2024 by IFRS

5/27/24 PHOR

Board of Directors of Phosagro recommended that dividends be paid for 3 months 2024

5/27/24 PHOR

Board of Directors of Rosneft Oil Company recommended that dividends be paid for 2023

5/27/24 ROSN

Board of Directors of Sistema recommended that dividends be paid for 2023

5/27/24 AFKS

Rostelecom is studying the possibility of entering the e-commerce market

5/27/24 RTKM

Board of Directors of Svetofor Group recommended that dividends be paid for 2023

5/27/24 SVET